OTC:AURX | Free Cash Flow | Nuo Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$784,272.00$847.00-$785,119.00
2025-12-31-$422,646.00$43,205.00-$465,851.00
2025-03-31$1,825.00$229,884.00-$228,059.00
2024-12-31-$490,539.00$0.00-$490,539.00
2024-03-31-$562,449.00$0.00-$562,449.00
2023-12-31-$671,407.00$0.00-$671,407.00
2023-03-31-$795,604.00$5,343.00-$800,947.00
2022-12-31-$821,686.00$4,649.00-$826,335.00
2022-03-31-$737,330.00$11,848.00-$749,178.00
2021-12-31-$106,953.00$0.00-$106,953.00
2021-03-31-$4,168.00$0.00-$4,168.00
2020-12-31-$33,568.00$0.00-$33,568.00
2019-12-31-$302,075.00
2019-03-31-$451,613.00
2018-12-31$386,756.00
2018-03-31-$546,580.00
2017-12-31-$1.2M
2017-03-31-$1.28M
2016-03-31-$2.55M$0.00-$2.55M
2015-12-31-$2.74M$427,355.00-$3.17M
2015-03-31-$3.96M$165,817.00-$4.13M-100.50%
2014-12-31-$3.82M$273,500.00-$4.09M-143.20%
2014-03-31-$3.91M$75,733.00-$3.99M
2013-12-31-$3.31M$150,324.00-$3.46M
2013-03-31-$4.21M
2012-12-31-$4.16M
2012-03-31-$508,531.00$275,818.00-$784,349.00
2011-12-31-$474,182.00$64,869.00-$539,051.00-60.07%
2011-03-31-$1.29M$1,561.00-$1.29M
2010-12-31-$640,252.00$745,299.00-$1.39M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$864,971.00$274,756.00-$1.14M
2024-12-31-$2.23M$154,962.00-$2.39M
2023-12-31-$3.17M$7,244.00-$3.18M
2022-12-31-$3.71M$59,992.00-$3.77M
2021-12-31-$119,955.00$0.00-$119,955.00
2020-12-31-$53,821.00$0.00-$53,821.00
2019-12-31-$921,674.00$0.00-$921,674.00
2018-12-31-$874,388.00
2017-12-31-$4.9M
2015-12-31-$14.39M$698,172.00-$15.09M
2014-12-31-$17.42M$482,962.00-$17.91M
2013-12-31-$11.4M$750,697.00-$12.15M
2012-12-31-$11.39M
2011-12-31-$4.24M$66,430.00-$4.31M
2010-12-31-$3.54M$774,625.00-$4.31M